Torrent Pharmaceuticals dividend and valuation
₹4,755.15Change from previous close: −0.14%Absolute change: −₹6.80
Valuation
Torrent Pharmaceuticals paid ₹32.00 per share in dividends over the last 12 months (yield 0.7%). Last ex-dividend date: June 20, 2025. The P/E ratio is 75.3. The average price target of 27 analysts is ₹4,080.22.
Data as of October 5, 2026
Valuation multiples
- Market cap
- ₹1.62T
- Enterprise value
- ₹1.37T
- P/E (trailing 12 months)
- 75.3
- Forward P/E
- 53.1
- PEG
- 2.75
- Price/book
- 19.1
- Price/sales
- 13.2
- EV/EBITDA
- 34.6
- EV/revenue
- 11.2
Profitability and growth
- Gross margin
- 75.7%
- Operating margin
- 26.6%
- Net margin
- 17.5%
- ROE
- 26.8%
- ROA
- 13.0%
- ROIC
- 9.1%
- Revenue growth (year over year)
- 14.3%
- Earnings growth (year over year)
- 30.5%
Financial health
- Total cash
- ₹7.94B
- Total debt
- ₹28.22B
- Debt/equity
- 0.33
- Current ratio
- 1.40
- Quick ratio
- 0.67
- Piotroski F-Score
- 4.00
Dividends
- Annual dividend per share
- ₹32.00
- Dividend yield
- 0.7%
- Payout ratio
- 50.6%
- Ex-dividend date
- June 20, 2025
Analysts and estimates
- Average price target
- ₹4,080.22
- Median price target
- ₹4,070.00
- High price target
- ₹4,620.00
- Low price target
- ₹3,530.00
- Analysts with a price target
- 27
- Forward EPS
- ₹89.60
- EPS estimate, current year
- ₹72.35
Shares and trading
- Beta
- 0.13
- Average volume
- 6.06K
- Shares outstanding
- 338.45M
- Float
- 104.06M
- Institutional ownership
- 14.5%
- Insider ownership
- 70.8%